Relationship between prenatal growth, postnatal growth and childhood obesity: a review

E K Matthews1, J Wei2, S A Cunningham3

  • 1Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Insights

Rapid postnatal growth increases childhood obesity risks for all birthweights. Prenatal growth patterns also influence these risks, particularly for infants born small. Further research is needed on combined growth effects.

Area of Science:

  • Pediatrics
  • Public Health
  • Developmental Biology

Background:

  • Obesity risks are established early in life.
  • Understanding early growth patterns is crucial for preventing childhood obesity.

Purpose of the Study:

  • To systematically review evidence on the relationship between prenatal growth, rapid postnatal growth, and childhood obesity risk.
  • To determine if rapid postnatal growth has differential implications for obesity risk based on prenatal growth patterns.

Main Methods:

  • Systematic database searches of PubMed and Embase conducted in October 2014.
  • Inclusion of 18 studies assessing prenatal and postnatal growth implications for childhood obesity.
  • Analysis of interaction effects between prenatal and postnatal growth on obesity risk.

Main Results:

  • Increased birthweight and rapid postnatal growth are associated with higher obesity risks across childhood.
  • Rapid postnatal growth showed a linear association with obesity in children of all birth sizes in most studies.
  • Some studies indicated an amplified obesity risk for small-for-gestational-age infants experiencing rapid postnatal growth.

Conclusions:

  • Both prenatal and postnatal growth are significant risk factors for developing childhood obesity.
  • The combined effects of prenatal and postnatal growth warrant further investigation to elucidate early obesity development.
  • Targeted interventions considering both growth phases may be necessary for obesity prevention.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.8K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320